Accessibility Menu
Organigram Global logo

Organigram Global(TSX) OGI

Market CapCA$238.82MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2014)-78%
5 Year-88%
1 Year-21%
1 Month+37%
CA$1.69
-3.43%
-0.06Today
Organigram Global last closing stock price
MetricPriceDate
Last closeCAD 1.692026-08-14
Organigram Global stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+23.36%CAD 1.372026-08-07
1 month+37.4%CAD 1.232026-07-15
3 month+14.19%CAD 1.482026-05-15
Year to date-26.84%CAD 2.312025-12-31
1 year-21.03%CAD 2.142025-08-14
3 year-5.06%CAD 1.782023-08-15
5 year-88.3%CAD 14.442021-08-13
Since inception-78.13%CAD 8.002014-08-26

Organigram Global Financials at a Glance

Market Cap

CA$238.82MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$309.18M

Net Income (TTM)

CA$86.62M

EPS (TTM)

CA$0.63

P/E Ratio

2.74

Dividend

CA$0.00

Beta (Volatility)

1.84 (High)

Price

CA$1.69

Volume

199,906

Open

CA$1.75

Previous Close

CA$1.69

Daily Range

CA$1.68 - CA$1.78

52-Week Range

CA$1.20 - CA$3.09

Estimated Earnings Date

Aug 11, 2026

OGI News

A chart line and arrow moving down.

Why Organigram Holdings Stock Is Plummeting Today

Keith NoonanApr 12, 2023
GettyImages-668519916

OrganiGram Releases Cannabis 2.0 Products To Medical Users

Bradley FreemanMay 28, 2020

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Organigram Global

Organigram Global Inc. is a Canadian company engaged in the production and sale of cannabis and cannabis-derived products. The company offers a diverse range of products for both medical and recreational use, catering to a growing market in Canada.

Products and Services
  • Medical cannabis products including whole flower, vapes, and concentrates
  • Recreational cannabis brands such as SHRED, Edison Cannabis Co., and Trailblazer
  • Wholesale shipping of cannabis plant cuttings and dried flowers
Growth Outlook
  • Recent quarterly revenue reached CAD 59.79 million, indicating strong market demand
  • Expansion into new product lines is expected to drive future growth
  • Strategic partnerships may enhance distribution channels and market reach
Financial Highlights
  • Trailing twelve months (TTM) revenue of CAD 263.5 million reflects a solid performance
  • Current ratio of 2.82 indicates strong liquidity and financial health
  • Net income for the latest quarter was CAD -0.92 million, showing potential for recovery
Organigram Global Inc. operates in the rapidly evolving cannabis industry, which presents significant opportunities for growth. The company's diverse product offerings and established brands position it well to capitalize on increasing consumer demand. Recent financial performance, including a notable quarterly revenue figure, suggests a positive trajectory. The company's strong liquidity, as indicated by its current ratio, further supports its operational capabilities. As the market continues to expand, Organigram's strategic initiatives may enhance its competitive edge and drive future profitability.
AI Generated • Jul 24, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

1,139

CEO

James Hideo Yamanaka, MBA

Website

www.organigram.ca

Headquarters

Toronto, ON M5H 1J8, CA

OGI Financials

Key Financial Metrics (TTM)

Gross Margin

-5.67%

Operating Margin

-37.35%

Net Income Margin

28.02%

Return on Equity

21.99%

Return on Capital

-24.68%

Return on Assets

10.56%

Earnings Yield

36.50%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

CA$238.82MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

136.47M

Volume

199.91K

Avg. Volume

217.03K

Financials (TTM)

Gross Profit

-CA$17.53M

Operating Income

-CA$115.47M

EBITDA

-CA$45.10M

Operating Cash Flow

-CA$27.93M

Capital Expenditure

-CA$1.13M

Free Cash Flow

-CA$29.06M

Cash & ST Invst.

CA$11.67M

Total Debt

CA$31.45M

Organigram Global Performance Analysis

Organigram Global annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-08-31CAD 145,809,00084.2%
20232023-09-30CAD 149,205,7282.3%
20242024-09-30CAD 159,841,0007.1%
20252025-09-30CAD 259,183,00062.2%
Organigram Global sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-09-3013.1%
Q12025-12-31-20.6%
Q22026-03-31-5.9%
Q32026-06-3076.9%
Organigram Global annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-08-31CAD -0.19-90.9%
20232023-09-30CAD -2.821425.9%
20242024-09-30CAD -0.48-83.1%
20252025-09-30CAD -0.19-59.3%
Organigram Global sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-09-30-495.7%
Q12025-12-31153.6%
Q22026-03-31-104.7%
Q32026-06-3011100.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

CA$105.78M

+49.4%

Gross Profit

CA$17.03M

-34.9%

Gross Margin

16.10%

N/A

Market Cap

CA$238.82MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

CA$213.23K

N/A

Employees

1,120

N/A

Net Income

CA$105.54M

+1776.8%

EBITDA

-CA$1.58M

-158.7%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Total Cash

CA$11.67M

-68.3%

Total Debt

CA$31.45M

+243.8%

Accounts Receivable

CA$88.61M

+54.0%

Inventory

CA$165.06M

+31.8%

Long Term Debt

CA$26.37M

+229.7%

Short Term Debt

CA$5.09M

+342.4%

Return on Assets

10.56%

N/A

Return on Invested Capital

-16.20%

N/A

Free Cash Flow

-CA$3.87M

-177.3%

Operating Cash Flow

-CA$4.30M

-129.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
TSND.TOTerrAscend Corp.
CA$0.81+0.00%
WEED.TOCanopy Growth Corporation
CA$1.38-2.13%
DR.TOMedical Facilities Corporation
CA$15.37+3.78%
XLY.TOAuxly Cannabis Group Inc.
CA$3.05+1.33%

Trending Stocks

Symbol / CompanyPricePrice Chg
NUNu Holdings
$15.23+0.09%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.76+0.01%
ONDSOndas
$9.24+0.04%
SPCXSpace Exploration Technologies
$140.00-0.01%

Questions About OGI

What is the current price of Organigram Global?

Organigram Global is trading at CA$1.69 per share.

What is the 52-week range for Organigram Global?

Over the past 52 weeks, Organigram Global has traded between CA$1.20 and CA$3.09.

How much debt does Organigram Global have?

As of the most recent reporting period, Organigram Global reported total debt of CA$31.45M.

How much cash does Organigram Global have on hand?

Organigram Global reported CA$10.85M in cash and cash equivalents in its most recent financial results.

What is Organigram Global’s dividend yield?

Organigram Global does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services